U.S. Physical Therapy (NYSE:USPH) Stock Price Crosses Above 200-Day Moving Average – What’s Next?

U.S. Physical Therapy, Inc. (NYSE:USPH)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $81.21 and traded as high as $83.55. U.S. Physical Therapy shares last traded at $82.2960, with a volume of 191,652 shares.

Wall Street Analyst Weigh In

USPH has been the topic of several recent analyst reports. Barrington Research restated an “outperform” rating and set a $103.00 price objective on shares of U.S. Physical Therapy in a report on Monday, January 5th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. Finally, JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $105.33.

U.S. Physical Therapy Price Performance

The firm has a market cap of $1.25 billion, a PE ratio of 34.58, a price-to-earnings-growth ratio of 3.40 and a beta of 1.29. The stock’s fifty day moving average price is $80.09 and its 200-day moving average price is $81.21. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.20 and a quick ratio of 1.20.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.01). The business had revenue of $197.13 million for the quarter, compared to analyst estimates of $193.98 million. U.S. Physical Therapy had a return on equity of 8.62% and a net margin of 5.71%.The business’s revenue was up 17.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.69 earnings per share. As a group, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Monday, November 17th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. U.S. Physical Therapy’s payout ratio is presently 75.63%.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of USPH. Cullen Frost Bankers Inc. grew its stake in shares of U.S. Physical Therapy by 171.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after buying an additional 280 shares during the period. Advisory Services Network LLC acquired a new position in U.S. Physical Therapy in the third quarter valued at approximately $39,000. EverSource Wealth Advisors LLC grew its position in U.S. Physical Therapy by 68.8% in the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock worth $40,000 after acquiring an additional 192 shares during the period. GAMMA Investing LLC grew its position in U.S. Physical Therapy by 207.1% in the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after acquiring an additional 348 shares during the period. Finally, Assetmark Inc. increased its stake in U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after acquiring an additional 150 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.